
SpaceX's IPO Offers Limited Access to Retail Investors, Experts Weigh In
SpaceX IPO Sets Off Frenzy Among Retail Investors
SpaceX's highly anticipated initial public offering, expected to fetch a valuation of $1.75 trillion, has sparked a frenzy among retail investors eager to get a piece of Elon Musk's rocket, satellite, and AI empire. Despite SpaceX's lack of profits, the IPO has attracted so much investor demand that bankers have already received twice as many orders as available shares.
Retail Investors to Get 30% of Shares
SpaceX has set aside as much as 30% or $22.5 billion in shares for retail investors, a rare move for a blockbuster IPO that typically favors institutional buyers. This allocation is a significant opportunity for individual investors to participate in the IPO, but it also raises the stakes for those who are eager to buy in.
Buying Shares in the IPO
Investors can buy shares in the SpaceX IPO through a handful of brokerage firms, including Fidelity, Robinhood Markets, SoFi, E*Trade, and Charles Schwab. To be eligible, investors typically need to have an account with one of these brokerages, meet minimum funding requirements, and submit an indication of interest before the IPO is priced. The requirements vary by brokerage, and there is no guarantee that an investor's order will be filled.
| Brokerage | Account Minimum |
|---|---|
| Fidelity Investments | $2,000 |
| Robinhood Markets | $0 |
| SoFi | $0 |
| E*Trade | $0 |
| Charles Schwab | $100,000 |
International Investors Face Additional Challenges
While SpaceX's IPO is being offered to investors in several countries, access varies significantly by market. International investors face additional eligibility requirements, limited share allocations, or regulatory restrictions compared to U.S. investors. Qualified investors in Germany, Denmark, France, the Netherlands, Norway, Spain, and Sweden will be able to buy shares once SpaceX's European prospectus is approved by regulators.
| Country | Eligibility Requirements |
|---|---|
| Argentina | |
| Australia | |
| Brazil | |
| Colombia | |
| Denmark | Qualified investors |
| European Economic Area | Qualified investors |
| France | Qualified investors |
| Germany | Qualified investors |
| India | |
| Israel | |
| Malaysia | |
| Mexico | |
| The Netherlands | Qualified investors |
| New Zealand | |
| Norway | Qualified investors |
| Peru | |
| Philippines | |
| Qatar | |
| Saudi Arabia | |
| Singapore | |
| South Africa | |
| South Korea | |
| Spain | Qualified investors |
| Sweden | Qualified investors |
| Switzerland | |
| Taiwan | |
| Thailand | |
| United Arab Emirates | |
| United Kingdom |
What Happens if You Don't Get an IPO Allocation?
Investors who do not receive shares in the IPO can still buy SpaceX stock once it begins trading on the public market on Friday. However, the shares may move sharply when trading opens, particularly if demand exceeds the number of shares available. In popular IPOs, stocks often have a "pop," soaring above their offering price on the first day, as investors who missed out on getting all the shares they wanted allocated at the IPO price chase a limited number of shares.
Risks to Consider
At roughly 110 times trailing sales, SpaceX's valuation assumes years of rapid growth, raising the stakes for investors if the company falls short of expectations. Some analysts have cautioned that SpaceX's valuation reflects lofty expectations for future growth, leaving little room for disappointment. Additionally, the company operates in a capital-intensive industry where launches, satellite deployments, and regulatory developments can affect financial performance.
Investor Takeaway
Investors should be cautious of the risks associated with buying shares in SpaceX's IPO, despite its potential for high returns.
More in IPO

Retail Investors to Participate in SpaceX's Upcoming IPO: A Guide to Accessing the Space Exploration Company's Shares

Hexagon Nutrition IPO Sees 1.65 Times Subscription, GMP Offers Glimpse into Second Bidding Day Prospects

Upcoming IPOs: Seven Listings Including CMR Green, Hexagon Nutrition, and a New SME Listing This Week
